Cytarabine - CYTARABINE
Navigation: NDC > Supplier starting with: H > HOSPIRA WORLDWIDE, INC.| Field | Value |
|---|---|
| NDC Code: | 61703-319 |
| Proprietary Name: | Cytarabine |
| Suffix: | |
| Non-Proprietary Name: | CYTARABINE |
| Dosage Form: | INJECTION, SOLUTION |
| Method: | INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS |
| Original Marketing Date: | 22-11-1999 |
| Category Name: | ANDA |
| Application Number: | ANDA075383 |
| Labeler: | HOSPIRA WORLDWIDE, INC. |
| Substance Name: | CYTARABINE |
| Active Numerator Strength: | 100 |
| Active Ingredient Unit: | mg/mL |
| Pharm Classes: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| DEA Schedule: |